AbstractOver the past 15 years, psychedelic treatments have garnered substantial clinical interest, with psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) advancing […]
Author: Clinical Editor
Updated Date: Mon, 16 Feb 2026 00:00:00 EST
What happened?The science funding body UK Research and Innovation (UKRI) is made up of seven research councils, including […]
As demand for glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy), and GLP-1 and glucose dependent […]
QUASAR long‑term extension results highlight durable clinical and endoscopic outcomes
MHRA authorises medicine for patients aged 12 and over with repeated flare‑ups
Titcombe’s article advocates a deeper systemic search for causes and solutions to failings in healthcare safety.1 The Department […]
Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring […]
Deep inside a Romanian ice cave, locked away in a 5,000-year-old layer of ice, scientists have uncovered a […]
A UK Supreme Court ruling could increase damages for children negligently brain damaged at birth.1Previously young children could […]